HomeNDRA • NASDAQ
ENDRA Life Sciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.47M | -47.16% |
Net income | -1.04M | 62.66% |
Net profit margin | — | — |
Earnings per share | -1.86 | 99.59% |
EBITDA | -1.46M | 47.29% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.06M | 81.98% |
Total assets | 3.17M | -37.35% |
Total liabilities | 1.42M | 4.05% |
Total equity | 1.75M | — |
Shares outstanding | 562.21K | — |
Price to book | 1.04 | — |
Return on assets | -96.37% | — |
Return on capital | -129.91% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -1.04M | 62.66% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$3.24
Day range
$3.07 - $3.38
Year range
$2.90 - $602.00
Market cap
1.82M USD
Avg Volume
336.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
21